NCT07219004View on ClinicalTrials.gov

Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

September 27, 2023

Study Completion Date

September 27, 2023

Conditions
Lower Extremity Chronic Ulcers in DiabeticsDiabetic Foot Ulcer (DFU)
Interventions
OTHER

amniotic membrane

The intervention is a trial-layer human amnion/chorion/amnion composite graft

Trial Locations (5)

14203

Serena Group Reseach Center, Buffalo

15146

Serena Group, Monroeville

34289

Three Rivers Wound and Hyperbaric Center, North Port

77437

El Campo Memorial Advanced Wound Care Clinic, El Campo

78701

The Serena Group Austin Research Center, Austin

Sponsors

Lead Sponsor

Tides Medical

Collaborators (1)

Serena Group
All Listed Sponsors
collaborator

Serena Group

OTHER

lead

Tides Medical

INDUSTRY

NCT07219004 - Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers. | Biotech Hunter | Biotech Hunter